Bayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited (formerly Cadila Healthcare) on Thursday announced the conclusion of their joint venture (JV) – Bayer Zydus Pharma Private Limited (BZPPL). The...
Novartis to buy radiology drug specialist Mariana for $1 billion
Novartis agreed to acquire U.S. radiopharmaceutical company Mariana Oncology for $1 billion upfront, boosting its portfolio of precision cancer treatments in development, the Swiss drug manufacturer said on Thursday...
Japan’s Ono to buy US drugmaker Deciphera for $2.4 bln
Deciphera Pharmaceuticals said on Monday Japan’s Ono Pharmaceutical Co will acquire the cancer drugmaker for $2.4 billion to expand its oncology portfolio and presence in the United States and Europe. Ono Pharma...
CVC explores options for Italy’s Recordati, Bloomberg News reports
CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC is working with advisers...
ChrysCap buys small stake in generics company La Renon for Rs 600 cr
The homegrown PE fund ChrysCapital has invested about Rs 600 crore ($70 million) in Ahmedabad-based La Renon Healthcare, valuing it at $800 million. ChrysCap has acquired about 8% stake from the promoter family in a...
Warburg buys majority stake in ophthalmic device company Appasamy
US private equity firm Warburg Pincus has bought a majority stake in Chennai-based Appasamy Associates, India’s largest maker of ophthalmic equipment and intraocular lenses (IOLs). Financial details of the...
Warburg Pincus acquires Chennai’s Appasamy Associates
Warburg Pincus, a leading global investor, has acquired a stake in leading manufacturer of ophthalmic equipment and devices Appasamy Associates, stated a company release. Based in Chennai, Appasamy is the largest Indian...
Denmark’s Genmab to acquire ProfoundBio for $1.8 billion
Danish biotech Genmab has agreed to buy privately owned U.S. cancer drug maker ProfoundBio for $1.8 billion, the two companies said on Wednesday. The acquisition will give Genmab worldwide rights to three candidates in...
Beige to offload 2.9% stake in Mankind Pharma through block deals
Beige Ltd., an affiliate of ChrysCapital, is looking to sell a portion of its stake in Mankind Pharma Ltd. through block deals. As per a term sheet reviewed by Mint, Beige Ltd. is offering to sell up to 11.63 million...
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to $1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease. The maker of hit...
AbbVie to bolster immunity illness drug pipeline with Landos deal
AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses, the companies said on Monday. Landos is...
AstraZeneca to buy fusion for $2 billion
AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals for $2 billion in cash as the drugmaker bets on next-generation cancer treatments. The deal gives AstraZeneca a foothold in the...
